DK1459739T3 - Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer - Google Patents

Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer

Info

Publication number
DK1459739T3
DK1459739T3 DK03006160T DK03006160T DK1459739T3 DK 1459739 T3 DK1459739 T3 DK 1459739T3 DK 03006160 T DK03006160 T DK 03006160T DK 03006160 T DK03006160 T DK 03006160T DK 1459739 T3 DK1459739 T3 DK 1459739T3
Authority
DK
Denmark
Prior art keywords
hydroscopic
quinoline carboxylic
pharmaceutical compositions
carboxylic acids
compositions containing
Prior art date
Application number
DK03006160T
Other languages
English (en)
Inventor
Adnan Dr Badwan
Lina Najati Nabulsi
Mahmoud M Omari
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Application granted granted Critical
Publication of DK1459739T3 publication Critical patent/DK1459739T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
DK03006160T 2003-03-19 2003-03-19 Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer DK1459739T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03006160A EP1459739B1 (en) 2003-03-19 2003-03-19 Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids

Publications (1)

Publication Number Publication Date
DK1459739T3 true DK1459739T3 (da) 2008-05-19

Family

ID=32798836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03006160T DK1459739T3 (da) 2003-03-19 2003-03-19 Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer

Country Status (7)

Country Link
US (1) US20040224014A1 (da)
EP (1) EP1459739B1 (da)
JP (1) JP2004339198A (da)
AT (1) ATE382338T1 (da)
DE (1) DE60318384T2 (da)
DK (1) DK1459739T3 (da)
ES (1) ES2297067T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006110815A1 (en) * 2005-04-11 2006-10-19 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
LT1901749T (lt) * 2005-05-18 2016-10-25 Raptor Pharmaceuticals Inc. Aerozoliniai fluorchinolinai ir jų naudojimas
RS52457B (en) 2006-12-13 2013-02-28 F. Hoffmann-La Roche Ag. POWDER FORMULATION FOR VALGANCICLOVIR
JP2012505222A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 肺炎症を低減するためのレボフロキサシンの吸入
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
AU2010289326B2 (en) 2009-09-04 2015-09-24 Horizon Therapeutics U.S. Holding Llc Use of aerosolized levofloxacin for treating cystic fibrosis
CN104039322A (zh) * 2011-11-30 2014-09-10 富山化学工业株式会社 含有1-环丙基-8-(二氟甲氧基)-7-[(1r)-1-甲基-2,3-二氢-1h-异吲哚-5-基]-4-氧代-1,4-二氢喹啉-3-羧酸的甲磺酸盐水合物的片剂
ES2768651T3 (es) 2013-04-25 2020-06-23 Kyorin Seiyaku Kk Composición farmacéutica sólida
CA2910121A1 (en) 2013-04-25 2014-10-30 Kyorin Pharmaceutical Co., Ltd. A pharmaceutical composition comprising a 1,4-dihydroquinoline carboxylic acid a cellulosic excipient and a salting-out agent
CA2965473A1 (en) 2014-10-23 2016-04-28 Kyorin-Pharmaceutical Co., Ltd. Solid pharmaceutical composition
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
CN107115312A (zh) * 2017-05-17 2017-09-01 湖南新汇制药股份有限公司 一种诺氟沙星片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IT1319664B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali.

Also Published As

Publication number Publication date
DE60318384D1 (de) 2008-02-14
DE60318384T2 (de) 2009-02-19
EP1459739A1 (en) 2004-09-22
EP1459739B1 (en) 2008-01-02
ATE382338T1 (de) 2008-01-15
ES2297067T3 (es) 2008-05-01
US20040224014A1 (en) 2004-11-11
JP2004339198A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
DK1459739T3 (da) Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer
HUP0303810A3 (en) Carboxylic acid derivative and salt thereof and pharmaceutical compositions containing them
DE60131088D1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
HK1131918A1 (en) Oral pharmaceutical formulations comprising salts of fenofibric acid
YU50401A (sh) Farmaceutski sastav koji sadrži inhibitore protonske pumpe
UY27320A1 (es) Nuevas composiciones farmacéuticas
RS54258B1 (en) SRC / ABL INHIBITOR FORMULATIONS
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
MA30554B1 (fr) Malates et formes polymorphes de l'acide ( 3s,5s)-7-[3-amino-5-methyl-piperidinyl ]-1-cyclopropyl-1,4-dihydro-8- methoxy-4-oxo-3-quinoleine-carboxylique
DK1396270T3 (da) Borsyresalte
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
IL174248A0 (en) Alkyl carboxylic acid derivatives and pharmaceutical compositions containing the same
ATE420638T1 (de) Stabile feste medizinische zusammensetzung für die orale verabreichung von ramosetron
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
ATE315395T1 (de) Pharmazeutische zusammensetzungen, die faropenem natrium und eine diamineacetat verbindung zur verbesserung der magen-darm trakt absorption enthalten
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
NO20021898L (no) Farmasoytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
TW200744583A (en) Statin stabilizing dosage formulations
PE20130180A1 (es) Soluciones farmaceuticas orales que comprenden telbivudina
UA94955C2 (en) Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
JO2567B1 (en) Non-water-absorbing pharmaceutical formula containing non-hydrated carboxylic quinoline acids
BR0318460A (pt) sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado
ATE355830T1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
MX2009010453A (es) Aminoacidos esenciales protegidos en el rumen.